The researchers said they launched the trial "because we saw patients getting blood clots and dying in front of us while on standard doses of preventative heparin," said study leader Dr.
that d-dimer levels more than four times the upper limit of normal are able to predict a very high-risk group of hospitalized COVID-19 patients - and giving therapeutic doses of heparin in these patients works," Spyropoulos said